The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chesnokova N.B.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Pavlenko T.A.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Beznos O.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Grigor'ev A.V.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

The role of the endothelin system in the pathogenesis of eye diseases

Authors:

Chesnokova N.B., Pavlenko T.A., Beznos O.V., Grigor'ev A.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2020;136(1): 117‑123

DOI: 10.17116/oftalma2020136011117

Read: 2634 times

Download PDF (RU)
Contact the author
Table of contents

THE ROLE OF THE ENDOTHELIN SYSTEM IN THE PATHOGENESIS OF EYE DISEASES
THE ROLE OF THE ENDOTHELIN SYSTEM IN THE PATHOGENESIS OF EYE DISEASES

To cite this article:

Chesnokova NB, Pavlenko TA, Beznos OV, Grigor'ev AV. The role of the endothelin system in the pathogenesis of eye diseases. Russian Annals of Ophthalmology. 2020;136(1):117‑123. (In Russ.)
https://doi.org/10.17116/oftalma2020136011117

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Approaches for improvement of ocular surface condition in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2024;(5):7-16
Obje­ctive stru­ctural and functional moni­toring of poly­peptide reti­nal neuroprotective therapy in diabetic reti­nopathy. Russian Annals of Ophthalmology. 2024;(5):97-104
Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
The resu­lts of fistulizing glaucoma surgeries in pseudophackic patients. Russian Annals of Ophthalmology. 2025;(1):45-52
The effect of vitrectomy on changes in mole­cular biomarker levels of the vitreous cavity in the early postoperative period in proliferative diabetic reti­nopathy. Russian Annals of Ophthalmology. 2025;(2):30-36
The effe­cts of intraoperative use of angiogenesis inhi­bitors on outcomes and complication rates in the surgical treatment of proliferative diabetic reti­nopathy. Russian Annals of Ophthalmology. 2025;(2):44-50
The possibilities of antioxidant neuroretinoprotection in the treatment of primary open-angle glaucoma. Russian Annals of Ophthalmology. 2025;(4):49-59
Electrophysiological methods in the diagnosis and moni­toring of glaucoma. Russian Annals of Ophthalmology. 2025;(4):102-109
The effect of initial conservative hypo­tensive therapy on the outcomes of sele­ctive laser trabeculoplasty in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2025;(5):16-22
Abstract:

The endothelin system (ES) plays a complex role in the pathogenesis of various eye diseases as a local regulator of vascular tone as well as many other physiological processes. Components of ES – endothelins and their receptors – can be found nearly in all cellular structures of the eye, their concentration increases in the presence of many eye diseases. In glaucoma, ES is involved in the mechanisms of eye hypertension by influencing the secretion and outflow of aqueous humor. The increase of endothelin level leads to the decrease of perfusion pressure, hypoxia, astrocyte proliferation, increase of density and rigidity of lamina cribrosa, apoptosis of neural cells, and has a profibrogenic effect. In retinal pathology, increase of endothelins disturbs autoregulation of retinal blood vessels changing the neurovascular interactions, breaks intercellular contacts in the retina, promotes neoangiogenesis. In diabetic retinopathy, ES contributes to the development of microangiopathy and proliferative vitreoretinopathy. The review discusses the possibility of correcting ES activity in the eye with medications by influencing its synthesis, cleavage and receptor binding.

Keywords:

endothelin
eye diseases
glaucoma
retinal pathology
diabetic retinopathy

Authors:

Chesnokova N.B.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Pavlenko T.A.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Beznos O.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Grigor'ev A.V.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Close metadata

References:

  1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):411-41. https://doi.org/10.1038/332411a0
  2. Golukhova EZ, Alieva AM, Kakuchaya TT, Arakelyan GG, Bulayeva NI. Endothelin as a modern biomarker of cardiovascular diseases. Kreativnaya cardiologiya. 2011;2:97-103. (In Russ.).
  3. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989;10(9):374-378. https://doi.org/10.1016/0165-6147(89)90011-4
  4. Shinkai M., Tsuruoka H., Wakabayashi S., Yamamoto Y., Takayanagi I. Pre- and postjunctional actions of endotelin in the rat iris sphincter preparation. Arch Pharmacol. 1994;350:63-67.
  5. Fernandez-Durango R, Rollin R, Mediero A, Roldan-Pallares M, Garcia Feijo J, Garcia Sanchez J. Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: expression of ETA and ETB receptors. Mol Vis. 2003;9: 103–109.
  6. Prasanna G, Dibas A, Tao W, White K, Yorio T. Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-alpha. Exp Eye Res. 1998;66(1):9–18. https://doi.org/10.1006/exer.1997.0407
  7. Tezel G, Kass MA, Kolker AE, Becker B, Wax MB. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6(2):83–89. https://doi.org/10.1097/00061198-199704000-00003
  8. Pavlenko T.A., Chesnokova N.B., Davydova N.G., Okhotsimskaia T.D., Beznos O.V., Grigor’ev A.V. Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy. Vestnik oftal’mologii. 2013;129(4):20-3. (In Russ.).
  9. Kurysheva NI, Tomilova IK, Kadykova EL, Deev AI, Nazarov SB, Nagornova ND. Nitric oxide in pathogenesis of cataract and glaucoma. Vestnik oftal’mologii. 2001;117(5):5-7. (In Russ.).
  10. Kurysheva NI, Irtegova EYu, Yasamanova AN, Kiseleva TN. Endothelial dysfunction and platelet hemostasis in primary open-angle glaucoma. Natsional’nyi zhurnal «Glaucoma». 2015;14(1):27-36. (In Russ.).
  11. Kurysheva NI, Irtegova EYu, Yasamanova AN. The role of endothelial dysfunction in glaucomatous optic neuropathy progression. Rossijskyi Oftal’mologitcheskyi zhurnal 2015;14(2):34-39. (In Russ.).
  12. 12.Henry E, Newby DE, Webb DJ, Hadoke PW, O’Brien CJ. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest Ophthalmol Vis Sci. 2006; 47(6):2528–2532. https://doi.org/10.1167/iovs.05-0240
  13. Emre M, Orgul S, Haufschild T, Shaw SG, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005; 89(1): 60–63. https://doi.org/10.1136/bjo.2004.046755
  14. Karadag R, Yagci R, Aydin B, Kanbay M, Erdurmus M, Keskin UC. Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients. Int Ophthalmol. 2009; 29(5):385–388. https://doi.org/10.1007/s10792-008-9253-z
  15. Nicolela MT, Ferrier SN, Morrison CA, Archibald ML, LeVatte TL, Wallace K, Chauhan BC, LeBlanc RP. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci. 2003; 44(6): 2565–2572.
  16. Choritz L, Rosenthal R, Fromm M. Pharmacological and functional characterization of endothelin receptors in bovine trabecular meshwork and ciliary muscle. Ophthalmic Res. 2005;37(4):179-87. https://doi.org/10.1159/000086471
  17. Cellini M, Versura P, Trere D, Campos EC. Effects of endothelin-1 on human trabecular meshwork cell contraction. Ophthalmic Res. 2005;37(1):43-49. https://doi.org/10.1159/000083021
  18. Erickson-Lamy K, Korbmacher C, Schuman JS, Nathanson JA. Effect of endothelin on outflow facility and accommodation in the monkey eye in vivo. Invest Ophthalmol Vis Sci. 1991; 32(3):492–495.
  19. Granstam E, Wang L, Bill A. Effects of endothelins (ET-1, ET-2 and ET-3) in the rabbit eye; role of prostaglandins. Eur J Pharmacol. 1991; 194(2-3):217–223.
  20. Okada K, Sugiyama K, Haque MS, Taniguchi T, Kitazawa Y. The effects of endothelin-1 on intraocular pressure and papillary diameter in rabbits Jpn J Ophthalmol. 1995;39(3):233-241.
  21. Hollo G, Lakatos P, Vargha P. Immediate increase in aqueous humour endothelin 1 concentration and intra-ocular pressure after argon laser trabeculoplasty in the rabbit. Ophthalmologica. 2000; 214(4):292–295. https://doi.org/10.1159/000027507
  22. Zhang X, Clark AF, Yorio T. Interaction of endothelin-1 with dexamethasone in primary cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44(12):5301-5308.
  23. Thieme H, Schimmat C, Münzer G, Boxberger M, Fromm M, Pfeiffer N, Rosenthal R. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2006;47(3):938-945. https://doi.org/10.1167/iovs.05-0527
  24. Kurashima H, Watabe H, Sato N, Abe S, Ishida N, Yoshitomi T. Effects of prostaglandin F2a analogues on endothelin-1-induced impairmentof rabbit ocular blood flow: comparison among tafluprost, travoprost,and latanoprost. Exp Eye Res. 2010;91(6):853-859. https://doi.org/10.1016/j.exer.2010.09.004
  25. Rosenthal R, Fromm M Endothelin antagonism as an active principle for glaucoma therapy. Br J Pharmacol. 2011; 162(4):806–816. https://doi.org/10.1111/j.1476-5381.2010.01103.x
  26. Chauhan BC, LeVatte TL, Jollimore CA, Yu PK, Reitsamer HA, Kelly ME. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004; 45(1):144–152.
  27. Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015; 6:21. https://doi.org/10.1186/s13167-015-0043-1
  28. Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ,Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002; 43(8):2704–2713.
  29. Howell GR, Macalinao DG, Sousa GS, Walden M, Soto I, Kneeland SL, Barbay JM, King BL, Marchant JK, Hibbs M, Stevens B, Barres BA, Clark AF, Libby RT, John SM. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121(4):1429–1444. https://doi.org/10.1172/JCI44646
  30. McGrady NR, Minton AZ, Stankowska DL, He S, Jefferies HB, Krishnamoorthy RR. Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma. BMC Neurosci. 2017; 18(1):27. https://doi.org/10.1186/s12868-017-0346-3
  31. Stokely ME, Brady ST, Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest Ophthalmol Vis Sci. 2002; 43(10):3223–3230.
  32. Lau J, Dang M, Hockmann K, Ball AK. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp Eye Res. 2006; 82(1):132–145. https://doi.org/10.1016/j.exer.2005.06.002
  33. Rodriguez-Pascual F, Busnadiego O, González-Santamaria J. The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases? Life Sci. 2014; 118:156–164. https://doi.org/10.1016/j.lfs.2013.12.024
  34. Shi-Wen X, Renzoni EA, Kennedy L, Howat S, Chen Y, Pearson JD, Bou-Gharios G, Dashwood MR, du Bois RM, Black CM, Denton CP, Abraham DJ, Leask A. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol. 2007; 26(8): 625–632. https://doi.org/10.1016/j.matbio.2007.06.003
  35. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells. Exp Eye Res. 2007; 84(6):1115–1124. https://doi.org/10.1016/j.exer.2007.02.010
  36. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res. 2008; 86(6):886–894. https://doi.org/10.1016/j.exer.2008.03.003
  37. Konno T, Maruichi M, Takai S, Oku H, Sugiyama T, Uchibori T. Effect of chymase on intraocular pressure in rabbits. Eur J Pharmacol. 2005; 524(1-3): 132–137. https://doi.org/10.1016/j.ejphar.2005.09.048
  38. Dibas A, Prasanna G, Yorio T. Localization of endothelin-converting enzyme in bovine optic nerve and retina. J Ocul Pharmacol Ther. 2005; 21(4): 288–297. https://doi.org/10.1089/jop.2005.21.288
  39. Wang RF, Podos SM, Serle JB, Baltatu OC. Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes. Curr Eye Res. 2011; 36(1):41–46. https://doi.org/10.3109/02713683.2010.512695
  40. Hollo G, Kothy P, Lakatos P, Vargha P. Endothelin-A receptor antagonist BQ-485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit. Ophthalmologica. 2002; 216:459–462. https://doi.org/10.1159/000067547
  41. Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003; 76(5):633–640.
  42. Resch H, Karl K, Weigert G et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009; 50(1):358–363. https://doi.org/10.1167/iovs.08-2460
  43. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol. 2008; 86(6):380–393. https://doi.org/10.1139/Y08-040
  44. Torbidoni V, Iribarne M, Ogawa L, Prasanna G, Suburo AM. Endothelin-1 and endothelin receptors in light-induced retinal degeneration. Exp Eye Res. 2005;81(3):265-75. https://doi.org/10.1016/j.exer.2004.12.024
  45. Rattner A1, Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci. 2005;25(18):4540-4549. https://doi.org/10.1523/JNEUROSCI.0492-05.2005
  46. Matsuo J, Oku H, Kanbara Y, Kobayashi T, Sugiyama T, Ikeda T. Involvement of NADPH oxidase and protein kinase C in endothelin-1-induced superoxide production in retinal microvessels. Exp Eye Res. 2009;89(5):693-699. https://doi.org/10.1016/j.exer.2009.06.012
  47. Kobayashi T, Oku H, Fukuhara M, Kojima S, Komori A, Ichikawa M, Katsumura K, Kobayashi M, Sugiyama T, Ikeda T. Endothelin-1 enhances glutamate-induced retinal cell death, possibly through ETA receptors. Invest Ophthalmol Vis Sci. 2005;46(12):4684-4690. https://doi.org/10.1167/iovs.05-0785
  48. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000;49(7):1239-1248.
  49. Adamiec-Mroczek J, Oficjalska-Mlynczak J, Misiuk-Hojlo M. Roles of endothelin-1 and selected proinflammatorycytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples. Cytokine. 2010;49(3):269-274. https://doi.org/10.1016/j.cyto.2009.11.004
  50. Chou JC, Rollins SD, Ye M, Batlle D, Fawzi AA. Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice. Invest Ophthalmol Vis Sci. 2014;55(4):2516-2525. https://doi.org/10.1167/iovs.13-13676
  51. Chakravarthy U, Hayes RG, Stitt AW, Douglas A. Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci. 1997; 38(10):2144–2151.
  52. Chang W, Lajko M, Fawzi AA (2018) Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes. PLoS ONE. 13(1):e0191285. https://doi.org/10.1371/journal.pone.0191285
  53. Qin D, Zhang L, Jin X, Zhao Z, Jiang Y, Meng Z. Effect of Endothelin-1 on proliferation, migration and fibrogenic gene expression in human RPE cells. Peptides. 2017;94:43-48. https://doi.org/10.1016/j.peptides.2017.06.004
  54. Mori F, King GL, Clermont AC, Bursell DK, Bursell SE. Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci. 2000;41(12):3955-3962.
  55. Chakrabarti S, Gan XT, Merry A, Karmazyn M, Sima AA. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res. 1998;17(3):301-307.
  56. Patel C, Narayanan SP, Zhang W, Xu Z\, Sukumari-Ramesh S, Dhandapani KM, Caldwell RW, Caldwell RB. Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy. Am J Pathol. 2014;184(11):3040-3051. https://doi.org/10.1016/j.ajpath.2014.07.012
  57. Grimshaw, M.J. Endothelins and hypoxia-inducible factor in cancer. Endocr Relat Cancer. 2007;14(2):233–244. https://doi.org/10.1677/ERC-07-0057
  58. Cabral T, Lima LH, Mello LGM, Polido J, Correa ÉP, Oshima A, Duong J, Serracarbassa P, Regatieri CV, Mahajan VB, Belfort R Jr. Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers. Ophthalmol Retina. 2018;2(1):31-37. https://doi.org/10.1016/j.oret.2017.04.004
  59. Kida T, Flammer J, Oku H, Morishita S, Fukumoto M, Suzuki H, Konieczka K, Ikeda T. Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision. EPMA J. 2016; 7(1):18. https://doi.org/10.1186/s13167-016-0066-2
  60. Salvatore S., Vingolo E.M. Endothelin-1 role in human eye: a review. J Ophthalmol. 2010; 2010:1–10. https://doi.org/10.1155/2010/354645
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.